Bill tracker, H.R. 2821, Health

FDA Modernization Act 3.0

  1. Introduced
  2. In committee
  3. Reported
  4. Passed the House
  5. Passed the Senate
  6. To the President
  7. Became law

Introduced Apr 10, 2025 with 41 cosponsors. Latest action Jul 21, 2026: Received in the Senate.

Sponsor

Committees

Timeline

CommitteeHouseSenatePresidentJulOct2026AprJulApr 10, 2025: Introduced in HouseApr 10, 2025: Referred to the House Committee on Energy and Commerce.Apr 10, 2026: Referred to the Subcommittee on Health.May 13, 2026: Subcommittee Consideration and Mark-up Session HeldMay 13, 2026: Forwarded by Subcommittee to Full Committee by Voice Vote.May 21, 2026: Committee Consideration and Mark-up Session HeldMay 21, 2026: Ordered to be Reported by the Yeas and Nays: 44 - 0.Jun 18, 2026: Reported by the Committee on Energy and Commerce. H. Rept. 119-706.Jun 18, 2026: Placed on the Union Calendar, Calendar No. 614.Jul 20, 2026: Mr. Guthrie moved to suspend the rules and pass the bill.Jul 20, 2026: Considered under suspension of the rules. (consideration: CR H4639-4640)Jul 20, 2026: DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.Jul 20, 2026: Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)Jul 20, 2026: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)Jul 20, 2026: Motion to reconsider laid on the table Agreed to without objection.Jul 21, 2026: Received in the Senate.
PassedFailed, tabled or vetoedBecame lawOther steps

What happened to it

Related bills

Full history

    • IntroducedSenate. Received in the Senate.
    • House. Motion to reconsider laid on the table Agreed to without objection.
    • House. On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
    • Passed the HousePassed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H4639)
    • House. DEBATE - The House proceeded with forty minutes of debate on H.R. 2821.
    • House. Considered under suspension of the rules. (consideration: CR H4639-4640)
    • House. Mr. Guthrie moved to suspend the rules and pass the bill.
    • On the calendarHouse. Placed on the Union Calendar, Calendar No. 614.
    • ReportedReported by the Committee on Energy and Commerce. H. Rept. 119-706.
    • Committee approvedHouse. Ordered to be Reported by the Yeas and Nays: 44 - 0.
    • House. Committee Consideration and Mark-up Session Held
    • HearingHouse. Forwarded by Subcommittee to Full Committee by Voice Vote.
    • HearingHouse. Subcommittee Consideration and Mark-up Session Held
    • HearingHouse. Referred to the Subcommittee on Health.
    • ReferredHouse. Referred to the House Committee on Energy and Commerce.
    • IntroducedIntroduced in House

Subjects

Administrative law and regulatory proceduresDepartment of Health and Human ServicesDrug safety, medical device, and laboratory regulationMedical researchResearch administration and funding

Read the bill on Congress.gov